Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPA-6566 in Primary Open-Angle Glaucoma or Ocular Hypertension
NCT01410188Phase 2Completed
- Sponsor
- Kubota Vision
- Start
- Sep 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OPA-6566 in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Kubota Vision. Started Sep 2011; status: completed.
02
Drugs
OPA-6566
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT01410188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01410188.